TrialThe Journal of clinical investigation2012
CHK1 targets spleen tyrosine kinase (L) for proteolysis in hepatocellular carcinoma.
Jian Hong et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
82 papers cite itlatest 60 shown
this paperpooled itcites it